Prime Medicine, Inc. (PRME) stock
PRMENasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$3.84−0.35 (-8.35%)
Close on Nov 17, 2026Market cap $696.49MP/E –Yield –
Prime Medicine price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Prime Medicine's price to book ratio was 19.5× on Nov 11, 2026, against 4.3× a year earlier. Over the last 4 years it ranged from 1.4× to 21.4×, with a median of 4.3×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 19.5× | +15.7 |
| 2025 | Dec 31, 2025 | 3.9× | +1.8 |
| 2024 | Dec 31, 2024 | 2.0× | −2.4 |
| 2023 | Dec 29, 2023 | 4.4× | – |
See a number that looks wrong?